BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Treatment
46 results:

  • 1. Gastric metastasis from breast cancer: five cases and a single-institutional review.
    Cheng M; Jia Z; Zhang G; Wang Y; Li S; Yang S; Li C; Geng C
    J Int Med Res; 2024 Mar; 52(3):3000605241233988. PubMed ID: 38483129
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinicopathological comparison between PTCL-TBX21 and PTCL-gata3 in Japanese patients.
    Shimasaki Y; Miyoshi H; Kawamoto K; Yoshida N; Mishina T; Nakashima K; Imamoto T; Sugio T; Yanagida E; Kato T; Yamada K; Takeuchi M; Suzuki T; Moritsubo M; Furuta T; Imaizumi Y; Takizawa J; Kato K; Suzumiya J; Suzuki R; Ohshima K
    Cancer Med; 2024 Feb; 13(3):e6793. PubMed ID: 38234210
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The gene expression profile and cell of origin of canine peripheral T-cell lymphoma.
    Owens E; Harris L; Harris A; Yoshimoto J; Burnett R; Avery A
    BMC Cancer; 2024 Jan; 24(1):18. PubMed ID: 38166662
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genes of Predisposition to Childhood Beta-Cell Acute Lymphoblastic Leukemia in the Kazakh Population.
    Svyatova G; Boranbayeva R; Berezina G; Manzhuova L; Murtazaliyeva A
    Asian Pac J Cancer Prev; 2023 Aug; 24(8):2653-2666. PubMed ID: 37642051
    [TBL] [Abstract] [Full Text] [Related]  

  • 5.
    Al-Zayan NR; Ashour MJ; Abuwarda HN; Sharif FA
    Pediatr Hematol Oncol; 2024; 41(2):103-113. PubMed ID: 37578068
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Frontline Management of Nodal Peripheral T-Cell lymphomas.
    Ngu HS; Savage KJ
    Am Soc Clin Oncol Educ Book; 2023 May; 43():e390334. PubMed ID: 37262395
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Value of Immunohistochemical Expression of TOX, ICOS, and GATA-3 in the Diagnosis of Mycosis Fungoides.
    Atwa HA; Abdelrahman DI
    Appl Immunohistochem Mol Morphol; 2023 Mar; 31(3):163-171. PubMed ID: 36805367
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma.
    Kameda T; Kataoka K; Kamiunten A; Hidaka M; Miyoshi H; Nakano N; Nosaka K; Yoshimitsu M; Yasunaga JI; Kogure Y; Shide K; Miyahara M; Sakamoto T; Akizuki K; Hidaka T; Kubuki Y; Koya J; Kawano N; Yamashita K; Kawano H; Toyama T; Maeda K; Marutsuka K; Imaizumi Y; Kato K; Sugio T; Tokunaga M; Tashiro Y; Takaori-Kondo A; Miyazaki Y; Akashi K; Ishitsuka K; Matsuoka M; Ohshima K; Watanabe T; Kitanaka A; Utsunomiya A; Ogawa S; Shimoda K
    Haematologica; 2023 Aug; 108(8):2178-2191. PubMed ID: 36794502
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Genetic alterations in new category of Peripheral T-cell lymphoma, not otherwise specified].
    Fukumoto K
    Rinsho Ketsueki; 2022; 63(12):1657-1667. PubMed ID: 36653140
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Single-cell analyses reveal novel molecular signatures and pathogenesis in cutaneous T cell lymphoma.
    Xue X; Wang Z; Mi Z; Liu T; Wang C; Shi P; Sun L; Yang Y; Li W; Wang Z; Liu H; Zhang F
    Cell Death Dis; 2022 Nov; 13(11):970. PubMed ID: 36400759
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell lymphoma Entities in the Routine Clinical Practice.
    Amador C; Bouska A; Wright G; Weisenburger DD; Feldman AL; Greiner TC; Lone W; Heavican T; Smith L; Pileri S; Tabanelli V; Ott G; Rosenwald A; Savage KJ; Slack G; Kim WS; Hyeh Y; Li Y; Dong G; Song J; Ondrejka S; Cook JR; Barrionuevo C; Lim ST; Ong CK; Chapman J; Inghirami G; Raess PW; Bhagavathi S; Gould C; Blombery P; Jaffe E; Morris SW; Rimsza LM; Vose JM; Staudt L; Chan WC; Iqbal J
    J Clin Oncol; 2022 Dec; 40(36):4261-4275. PubMed ID: 35839444
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): Retrospective data from a Latin American cohort.
    de Pádua Covas Lage LA; Brito CV; Levy D; Culler HF; Freitas Couto SC; de Oliveira LBA; Nogueira Zerbini MC; Rocha V; Pereira J
    Leuk Res; 2022 Mar; 114():106794. PubMed ID: 35131666
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Fifteen-year follow-up of relapsed indolent non-Hodgkin lymphoma patients vaccinated with tumor-loaded dendritic cells.
    Fucà G; Ambrosini M; Agnelli L; Brich S; Sgambelluri F; Mortarini R; Pupa SM; Magni M; Devizzi L; Matteucci P; Cabras A; Zappasodi R; De Santis F; Anichini A; De Braud F; Gianni AM; Di Nicola M
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34127544
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Chemotherapy treatments for Burkitt lymphoma: Systematic Review of Interventional Studies.
    Della Rocca AM; Leonart LP; Ferreira VL; Tonin FS; Steffenello-Durigon G; Del Moral JAG; Fernandez-Llimos F; Pontarolo R
    Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):514-525. PubMed ID: 33947633
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Primary cutaneous peripheral T-cell lymphoma, not otherwise specified: results of a multicentre European Organization for Research and treatment of Cancer (EORTC) cutaneous lymphoma taskforce study on the clinico-pathological and prognostic features.
    Kempf W; Mitteldorf C; Battistella M; Willemze R; Cerroni L; Santucci M; Geissinger E; Jansen P; Vermeer MH; Marschalko M; Papadavid E; Piris MA; Ortiz-Romero PL; Novelli M; Paulli M; Quaglino P; Ranki A; Rodríguez Peralto JL; Wobser M; Auschra B; Robson A
    J Eur Acad Dermatol Venereol; 2021 Mar; 35(3):658-668. PubMed ID: 32997839
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Association of gata3 Polymorphisms With Minimal Residual Disease and Relapse Risk in Childhood Acute Lymphoblastic Leukemia.
    Zhang H; Liu AP; Devidas M; Lee SH; Cao X; Pei D; Borowitz M; Wood B; Gastier-Foster JM; Dai Y; Raetz E; Larsen E; Winick N; Bowman WP; Karol S; Yang W; Martin PL; Carroll WL; Pui CH; Mullighan CG; Evans WE; Cheng C; Hunger SP; Relling MV; Loh ML; Yang JJ
    J Natl Cancer Inst; 2021 Apr; 113(4):408-417. PubMed ID: 32894760
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. High-dose rituximab in combination with autologous stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma.
    Shi YF; Zhou SJ; Sun L; Yu K; Chen Y
    Med Clin (Barc); 2020 Sep; 155(6):235-241. PubMed ID: 32173075
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy.
    Menter T; Tzankov A; Zucca E; Kimby E; Hultdin M; Sundström C; Beiske K; Cogliatti S; Banz Y; Cathomas G; Karjalainen-Lindsberg ML; Grobholz R; Mazzucchelli L; Sander B; Hawle H; Hayoz S; Dirnhofer S
    Br J Haematol; 2020 May; 189(4):707-717. PubMed ID: 32012230
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no gata3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma.
    Kim HJ; Kim HK; Park G; Min SK; Cha HJ; Lee H; Choi SJ; Na HY; Choe JY; Kim JE
    Diagn Pathol; 2019 Dec; 14(1):133. PubMed ID: 31831043
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A novel method to establish glucocorticoid resistant acute lymphoblastic leukemia cell lines.
    Gu L; Zhang G; Zhang Y
    J Exp Clin Cancer Res; 2019 Jun; 38(1):269. PubMed ID: 31221196
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.